News

CNV Analysis Reveals Genetic Basis for ADHD


 

Major Finding: The genome-wide burden of CNVs was significantly greater in the ADHD patients, compared with the controls (rates of 0.156 vs. 0.075, respectively).

Data Source: A genome-wide analysis of CNVs in 366 children with ADHD and 1,047 controls.

Disclosures: The study was funded primarily by Wellcome Trust. Additional funding was provided by Action Research, Baily Thomas Charitable Trust, UK Medical Research Council, and the European Union. Study authors stated that they had no conflicts to report.

Attention-deficit hyperactivity disorder is a neurodevelopmental disorder, rather than a purely social construct, according to British researchers who have found that a type of genetic variation associated with brain disorders such as schizophrenia and autism also occurs in excess in ADHD patients.

The findings, published online in The Lancet, provide the first direct evidence of a genetic basis for ADHD, Dr. Nigel Williams of Cardiff University, Wales, and his colleagues reported.

The investigators performed a genome-wide analysis of large, rare chromosomal deletions and duplications known as copy number variants (CNVs) in 366 children with ADHD and 1,047 controls.

The genome-wide burden of CNVs was significantly greater in the ADHD patients, compared with that in the controls — rates of 0.156 and 0.075, respectively, they found (Lancet 2010 Sept. 30 [doi:10.1016/S0140-6736(10)61109-9]).

The CNVs identified in this study are similar to those found in patients with schizophrenia and autism, and are significantly enriched for loci that have previously been implicated in those disorders, with particular overlap at a region on chromosome 16 that spans a number of genes, including one that affects brain development.

Furthermore, although the rate of CNVs was significantly higher in children with ADHD with and without intellectual disability, compared with the general population, the rate was particularly high in those with intellectual disability, defined as those with an IQ of less than 70 (rates of 0.424 and 0.075, respectively).

The findings are noteworthy because despite evidence that ADHD might be a genetic condition — for example, it has an estimated heritability of 76% — there has been a great deal of debate over whether it is a result of bad parenting or other external factors, coauthor Dr. Anita Thapar said during a press conference on the findings.

“ADHD can be stigmatizing … and finding this direct genetic link to ADHD should help clear this misunderstanding and address this issue of stigma,” said Dr. Thapar, professor of child and adolescent psychiatry at Cardiff University.

In addition to providing a window into the biology of the brain, the findings will also influence the way in which ADHD is classified and will improve communication between scientists and clinicians about “what we mean by ADHD,” she said.

“This will be the start of a much more scientific venture because our findings are going to help us unravel the biologic basis of ADHD, and that's going to be really important in turn in the further future to help us develop new and much more effective treatments for affected individuals.”

The subjects were recruited from community clinics and had met diagnostic criteria for ADHD or hyperkinetic disorder. They were aged 5-17 years (mean, 10.5 years), were of white U.K. origin, and had a mean IQ of 86. Controls were unrelated, ethnically matched children from the 1958 British Birth Cohort.

The findings have important clinical and research implications. “First, our results emphasize that further investigation of CNVs in ADHD is a priority for research into this disorder,” the investigators wrote.

Also, the finding that more than a third of ADHD children with intellectual disability carried a large, rare CNV — and the fact that none of these children had been assessed for this type of mutation by clinical services — suggest that routine referral to clinical geneticists and screening for such mutations could be helpful for children with ADHD who also have intellectual disability, they said.

View on the News

New Insights on Brain Development

The findings of this study provide “a new chapter to the genetics of neurodevelopmental disorders,” Dr. J. Peter H. Burbach said.

Not only do they give insight into the neurological basis of ADHD, they also show that ADHD shares specific genes with autism, schizophrenia, and mental retardation. In particular, they highlight the importance of the chromosome 16p13.11 region previously implicated in these and other brain disorders, he said.

However, although the findings are exciting, it remains unclear how they will be clinically translated, he said, noting that to help clinician's better understand and interpret the diversity of neuropsychiatric phenotypes in light of these findings about overlapping genotypes, future studies should explore in more detail how the genotypes and phenotypes are linked.

Pages

Recommended Reading

New Data Find No Link Between Menactra, GBS
MDedge Neurology
'Definitive' Study: VZV Shot Not Tied to Ischemic Stroke
MDedge Neurology
HPV Vaccine May Not Increase Guillain-Barré Syndrome Risk
MDedge Neurology
Early Postconcussion Return to Play Discouraged
MDedge Neurology
Rapid Drop in CBF Seen at Age 12
MDedge Neurology
Myelopathy in Pediatric Spine Trauma Needs MRI
MDedge Neurology
Cine MRI Offers Insights Into Kids' Obstructive Sleep Apnea
MDedge Neurology
Imaging Duo Sharpens Tumor Diagnosis Accuracy
MDedge Neurology
Auditory Response Delays May Fuel Language Deficit in Autism
MDedge Neurology
Postnatal Gene Therapy Found Effective in SMA Mouse
MDedge Neurology